About Psilera bioscience

About company

Many pharmaceutical drugs originate from nature due to intrinsic biodiversity, biological activity, and safety that has been optimized throughout time. A shift towards natural products is evident from significant interest and clinical data identifying cannabis and psychedelics as emerging therapeutics. Psilera will leverage its research strength being lead by executives from the pharmaceutical and cannabis industries to develop a best-in-class IP portfolio of analogues based on psychoactive precursors. Lead compounds are formulated and screened against neurological targets to evaluate clinical potential with pipeline candidates in the areas of mood disorders, cognitive diseases, and addiction. Psilera’s mission is to make a significant impact on mental health and reduce human suffering.